Given its crucial role in mediating immune tolerance and its relationship with T cell exhaustion during chronic viral infection and cancer (34, 35), Tim-3 has begun to attract attention as a plausible target in cancer immunotherapy. This evidence concerns the gene HAVCR2 and cancer.